ARTICLE #13 OF 100
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
ARTICLE IN NATURE
An initial trial of an antibody therapy represents a positive step towards finding a treatment for early-stage Alzheimer's disease.